2m 2m 2m 2m 2m 2m 2m
- $101.5BMarket Cap
- -7.46%1-Year Change
- Medical DevicesIndustry
Medtronic (MDT)
Key Performance
More- Earnings Score: 55
- Momentum Score: 58
- True Yield: 59
- Financial Health Score: 35
Latest Research & News
The global blood glucose monitoring system market is valued at USD 16.8 billion in 2025 and is projected to reach USD 39.4 billion by 2035, growing at a CAGR of 8.9%. Growth is driven by AI-enabled monitoring systems, increasing diabetes prevalence, and rising adoption of home healthcare solutions. Key players include Medtronic, Abbott, Dexcom, and Roche, with recent partnerships like Abbott-Medtronic collaboration to integrate continuous glucose monitoring with automated insulin delivery systems.
07/14/2026, 12:30 AM • GlobeNewswire
Disposable Endoscopes Market Size Projected to Hit USD 10.47 Billion by 2035 | SNS Insider
The global disposable endoscopes market is expected to expand at a CAGR of 15.04% through 2035, driven by rising infection prevention initiatives, adoption of single-use endoscopes, and minimally invasive procedures. North America leads with 38.45% market share, while Asia Pacific records the fastest growth. Hospitals dominate the end-user segment with 55.36% market share, with ambulatory surgical centers showing the highest growth potential.
07/13/2026, 11:00 AM • GlobeNewswire
Explosive Growth in AI for Orthopedic Surgery Market: $0.87 Billion by 2030 at 27.2% CAGR
The AI in orthopedic surgery market is experiencing remarkable growth with a projected CAGR of 27.2% through 2030. Key drivers include rising musculoskeletal disorders, AI-assisted surgical planning, robotic surgical systems integration, and enhanced implant placement precision. North America leads the market, while Asia-Pacific and Europe show growing segments despite tariff-related challenges.
07/10/2026, 10:56 AM • GlobeNewswire
A comprehensive patent landscape analysis of surgical navigation systems reveals 2,524 patents filed globally from 2010-2025, with the United States leading at 1,204 patents. The global market was valued at USD 8.38 billion in 2024 and is projected to reach USD 18.47 billion by 2030 at a 14% CAGR. Key drivers include AI-guided support, augmented reality, and robotic integration, with North America dominating and Asia-Pacific as the fastest-growing region. Major players include Brainlab AG, Medtronic, and Stryker.
07/09/2026, 6:52 AM • GlobeNewswire
AI, Cybersecurity, and Interoperable Systems: Core Pillars Driving the Smart Hospital Evolution
The global Smart Hospitals Market is projected to grow from USD 90.82 billion in 2026 to USD 206.71 billion by 2032, with a CAGR of 14.56%. Growth is driven by AI integration, connected medical devices, and digital health initiatives across APAC, Europe, and North America. Key focus areas include precision medicine, operational efficiency, and cybersecurity implementation.
07/08/2026, 4:20 AM • GlobeNewswire
Intuitive Surgical's Moat Is Getting Stronger. Is This the Closest Thing to a 'Forever' Stock?
Intuitive Surgical maintains a dominant position in the robotic surgery market with its Da Vinci system, which benefits from strong competitive moats including surgeon training, high switching costs, and deep operating room integration. The company's recurring revenue model—driven primarily by accessories, instruments, and service contracts rather than system sales—supports steady earnings growth. Despite new competition from Medtronic's Hugo system, Intuitive Surgical's broad market presence and established leadership position its moat as increasingly stronger.
07/01/2026, 5:10 AM • The Motley Fool
Medtronic Data Breach Exposes Personal Information: Murphy Law Firm Investigates Legal Claims
Medtronic discovered a data breach in April 2026 where cybercriminals accessed its inadequately secured network, compromising sensitive personal information of hundreds of thousands of individuals including names, Social Security numbers, medical information, addresses, and dates of birth. Murphy Law Firm is investigating potential class action lawsuits to seek compensation for affected individuals.
06/30/2026, 7:26 PM • GlobeNewswire
SPR Wins Fifth Consecutive Northeast Ohio Top Workplaces Award
SPR, a medical device company specializing in peripheral nerve stimulation (PNS) for pain management, has been named a Top Workplace by Northeast Ohio Top Workplaces for the fifth consecutive year. The recognition reflects the company's strong workplace culture amid significant growth, including doubled employee count and surpassed 50,000 patients treated with its SPRINT PNS System. SPR announced that Medtronic intends to acquire the company, a partnership expected to expand the SPRINT PNS reach to more patients.
06/29/2026, 9:00 AM • GlobeNewswire
Orchestra BioMed Joins Russell 3000® and Russell 2000® Indexes
Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) announced its inclusion in the Russell 3000 Index and Russell 2000 Index following the 2026 Russell indexes reconstitution effective June 26, 2026. The biomedical company develops AVIM Therapy for hypertension in collaboration with Medtronic and Virtue SAB for atherosclerotic artery disease, both undergoing pivotal clinical trials.
06/29/2026, 8:00 AM • GlobeNewswire
3 Stocks I'm Not Selling No Matter What the Market Does
An investor outlines three dividend stocks he plans to hold through market downturns: Medtronic (a medical device company with 49 years of dividend increases), Realty Income (a REIT with 31 years of dividend growth and 5.2% yield), and Nucor (a steel maker with 50+ consecutive annual dividend hikes). The author argues that well-run companies remain well-run regardless of market conditions and represent solid long-term holdings.
06/27/2026, 6:15 PM • The Motley Fool
Brain Implants Market Size to Reach USD 18.39 Billion by 2035, Growing at 9.99% CAGR | SNS Insider
The global brain implants market, valued at USD 7.10 billion in 2025, is projected to reach USD 18.39 billion by 2035, growing at a CAGR of 9.99%. Growth is driven by rising prevalence of neurological disorders and increasing adoption of deep brain stimulation, neuromodulation systems, and brain-computer interfaces. North America leads the market, with the U.S. expected to grow from USD 3.16 billion to USD 8.17 billion by 2035.
06/27/2026, 4:30 AM • GlobeNewswire
2 High-Yield Dividend Stocks to Buy and Hold for a Decade
The article recommends Pfizer and Medtronic as attractive dividend stocks for long-term investors seeking portfolio stability amid economic uncertainties. Despite recent challenges, both healthcare leaders offer compelling dividend yields (6.8% and 3.6% respectively) and have strong pipelines and growth opportunities that could drive returns over the next decade.
06/23/2026, 4:30 PM • The Motley Fool
The global healthcare services market is projected to grow from USD 8.62 trillion in 2025 to USD 20.10 trillion by 2035, with a CAGR of 8.87%. Growth is driven by rising chronic disease prevalence, aging populations, and digital healthcare adoption including telehealth and AI-enabled care. The U.S. market is expected to reach USD 4.93 trillion and Europe USD 6.25 trillion by 2035. Hospital services will dominate with 44% market share, while telehealth services will experience the fastest growth.
06/20/2026, 4:27 AM • GlobeNewswire
Microcatheter Market Size to Reach USD 1.79 Billion by 2035 | SNS Insider
The global microcatheter market is valued at USD 1.05 billion in 2025 and is projected to reach USD 1.79 billion by 2035, expanding at a CAGR of 5.53%. Growth is driven by increasing adoption of minimally invasive cardiovascular and neurovascular procedures, rising prevalence of cardiovascular and neurovascular disorders, and advancements in catheter technologies. Aspiration microcatheters lead with 36% market share, while steerable microcatheters are the fastest-growing segment. North America dominates with 34% of global revenues, with Asia-Pacific emerging as the fastest-growing region.
06/19/2026, 5:09 AM • GlobeNewswire
Billionaire Ken Griffin Sold Amazon and Nvidia but Quietly Loaded Up on This Healthcare Giant
Ken Griffin's Citadel Advisors reduced positions in Nvidia and Amazon during Q1 while increasing its stake in Intuitive Surgical by 30.3%. Despite the medical device company facing headwinds from competition, lower margins on new products, and tariffs, analysts believe its strong competitive moat, large addressable market, and AI integration potential make it an attractive long-term investment at current valuations.
06/16/2026, 4:30 PM • The Motley Fool
Peers
Statistics
MoreInformation as of 07/15/2026
Company Profile
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring sys
Key Executives
- Geoffrey Straub Martha
- Brett A. Wall
- Michelle Quinn
- Thierry Pieton
- Laura Mauri
Current Ownership Distribution
- Institutions19.3B (82.35%)
- Mutual Funds4.1B (17.61%)
- Insiders7.4M (0.03%)
- Other0 (0.00%)